Previous 10 | Next 10 |
home / stock / prn:cc / prn:cc news
Baytex Energy Corp. (BTE:CA) is expected to report $0.23 for Q3 2023 Logistec Corporation Class A Common Shares (LGT.A:CA) is expected to report for Q1 2024 ARC Resources Ltd. (ARX:CA) is expected to report $0.48 for Q3 2023 Lightspeed Commerce Inc. Subordinate Voting Shares (LSPD:CA)...
Profound Medical Corp. (PRN:CA) is expected to report $-0.43 for Q3 2023
TORONTO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, wi...
TORONTO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, an...
2023-09-25 16:40:27 ET More on Profound Medical Seeking Alpha’s Quant Rating on Profound Medical Historical earnings data for Profound Medical Financial information for Profound Medical Profound Medical Corp. (PROF) Q2 2023 Earnings Call Transcript ...
TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, t...
TORONTO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, w...
TORONTO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, t...
2023-09-18 16:36:29 ET More on Profound Medical Seeking Alpha’s Quant Rating on Profound Medical Historical earnings data for Profound Medical Financial information for Profound Medical Profound Medical Corp. ( PROF ) Q2 2023 Earnings Call Transc...
2023-09-07 02:37:54 ET Profound Medical ( NASDAQ: PROF ) announced an at-the-market equity program that allows the company, through certain securities dealers acting as agents, to issue and sell from time to time up to $30M of shares. The timing and extent of the us...
News, Short Squeeze, Breakout and More Instantly...
Profound Medical Corp. Company Name:
PRN:CC Stock Symbol:
TSXC Market:
Profound Medical Corp. Website:
TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today ...
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual General Meeting of Shareholders that was held today (the “Meeting”). A total ...
PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS Canada NewsWire TORONTO , May 15, 2024 /CNW/ - Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General ...